These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17897036)

  • 1. Complementarity between public and commercial databases: new opportunities in medicinal chemistry informatics.
    Southan C; Várkonyi P; Muresan S
    Curr Top Med Chem; 2007; 7(15):1502-8. PubMed ID: 17897036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of the expanding complementarity between public and commercial databases of bioactive compounds.
    Southan C; Várkonyi P; Muresan S
    J Cheminform; 2009 Jul; 1(1):10. PubMed ID: 20298516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parallel worlds of public and commercial bioactive chemistry data.
    Lipinski CA; Litterman NK; Southan C; Williams AJ; Clark AM; Ekins S
    J Med Chem; 2015 Mar; 58(5):2068-76. PubMed ID: 25415348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of commercial and public bioactivity databases.
    Tiikkainen P; Franke L
    J Chem Inf Model; 2012 Feb; 52(2):319-26. PubMed ID: 22145975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico techniques for the identification of bioisosteric replacements for drug design.
    Devereux M; Popelier PL
    Curr Top Med Chem; 2010; 10(6):657-68. PubMed ID: 20337588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracting and connecting chemical structures from text sources using chemicalize.org.
    Southan C; Stracz A
    J Cheminform; 2013 Apr; 5(1):20. PubMed ID: 23618056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the consistency of medicinal chemists in reviewing sets of compounds.
    Lajiness MS; Maggiora GM; Shanmugasundaram V
    J Med Chem; 2004 Sep; 47(20):4891-6. PubMed ID: 15369393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PubChem applications in drug discovery: a bibliometric analysis.
    Cheng T; Pan Y; Hao M; Wang Y; Bryant SH
    Drug Discov Today; 2014 Nov; 19(11):1751-1756. PubMed ID: 25168772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping between databases of compounds and protein targets.
    Muresan S; Sitzmann M; Southan C
    Methods Mol Biol; 2012; 910():145-64. PubMed ID: 22821596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding opportunities for mining bioactive chemistry from patents.
    Southan C
    Drug Discov Today Technol; 2015 Jul; 14():3-9. PubMed ID: 26194581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Playbooks of Medicinal Chemistry Design Moves.
    Awale M; Hert J; Guasch L; Riniker S; Kramer C
    J Chem Inf Model; 2021 Feb; 61(2):729-742. PubMed ID: 33522806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bridging informatics and medicinal inorganic chemistry: Toward a database of metallodrugs and metallodrug candidates.
    Medina-Franco JL; López-López E; Andrade E; Ruiz-Azuara L; Frei A; Guan D; Zuegg J; Blaskovich MAT
    Drug Discov Today; 2022 May; 27(5):1420-1430. PubMed ID: 35227887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capturing structure-activity relationships from chemogenomic spaces.
    Wendt B; Uhrig U; Bös F
    J Chem Inf Model; 2011 Apr; 51(4):843-51. PubMed ID: 21410249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving usability and accessibility of cheminformatics tools for chemists through cyberinfrastructure and education.
    Guha R; Wiggins GD; Wild DJ; Baik MH; Pierce And ME; Fox GC
    In Silico Biol; 2011-2012; 11(1-2):41-60. PubMed ID: 22475751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicinal chemistry tools: making sense of HTS data.
    Kolossov E; Lemon A
    Eur J Med Chem; 2006 Feb; 41(2):166-75. PubMed ID: 16368163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making every SAR point count: the development of Chemistry Connect for the large-scale integration of structure and bioactivity data.
    Muresan S; Petrov P; Southan C; Kjellberg MJ; Kogej T; Tyrchan C; Varkonyi P; Xie PH
    Drug Discov Today; 2011 Dec; 16(23-24):1019-30. PubMed ID: 22024215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular scaffold analysis of natural products databases in the public domain.
    Yongye AB; Waddell J; Medina-Franco JL
    Chem Biol Drug Des; 2012 Nov; 80(5):717-24. PubMed ID: 22863071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Financing a future for public biological data.
    Ellis LB; Kalumbi D
    Bioinformatics; 1999 Sep; 15(9):717-22. PubMed ID: 10498771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BioVenn - a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams.
    Hulsen T; de Vlieg J; Alkema W
    BMC Genomics; 2008 Oct; 9():488. PubMed ID: 18925949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the likelihood of an active compound to be promiscuous? Systematic assessment of compound promiscuity on the basis of PubChem confirmatory bioassay data.
    Hu Y; Bajorath J
    AAPS J; 2013 Jul; 15(3):808-15. PubMed ID: 23605807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.